Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Age-related macular degeneration (AMD) is one of the leading causes of vision ... Since AMD is closely linked with aging, some researchers have turned their attention to metformin—a drug better known ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following a U.S. appeals court ruling ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.